跳至主要内容
临床试验/DRKS00004159
DRKS00004159已完成不适用

Investigation and validation of the diagnostic performance of new biomarker candidates for (I) the early detection of an infectious origin of neutropenic fever and for the prediction of (II) an infection of patients after apoplectic stroke and the progression of (III) a nosocomial infection or (IV) a community acquired pneunomia to a severe sepsis/ septic shock - Lab-ALERTS

Institut für Klinische Chemie und Laboratoriumsdiagnostik / Integriertes Forschungs- und Behandlungszentrum Sepsis und Sepsisfolgen0 个研究点目标入组 1,018 人开始时间: 2012年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,018

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • I) patients with hemato-malignancies who are expected to develop neutropenia during/ after chemotherapy, age = 18 (297 patients, recruitment in this study);
  • II) Ischemic stroke in the territory of A. cerebri media (or beyond), age = 18, NIH stroke score (NIHSS) > 8 (136 patients, recruitment in PRED-SEP study, DRKS00003392);
  • III) hospital stay of >48 hours and nosocomial infection (4219 patients, recruitment in this study);
  • IV) patienten with community acquired pneumonia (400 patients, recruitment in PROGRESS-CAP study)

排除标准

  • II) infection present upon hospital atmittance; anamnesis of a previous stroke; cardiac arrhythmia;

研究者

发起方
Institut für Klinische Chemie und Laboratoriumsdiagnostik / Integriertes Forschungs- und Behandlungszentrum Sepsis und Sepsisfolgen

相似试验